New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

Can a diet pill treat cancer? There is fresh evidence that indicates type 2 diabetes and obesity medications GLP-1 receptor ...

New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

Weight loss jabs could “herald a whole new era of preventative cancer medicine” by slashing risk of obesity-related tumours, ...

A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond ...